Overview
Peter Crow is a Hematologist Oncology specialist and an Oncologist in Concord, New Hampshire. Dr. Crow is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Richter Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
250 Pleasant St, Concord, NH 03301
Maine Center For Cancer Medicine And Blood Disorders PA
Devon Evans is a Hematologist and an Oncologist in Portsmouth, New Hampshire. Dr. Evans is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Pancreatic Cancer, Astrocytoma, and Bone Marrow Aspiration.
Douglas Weckstein is a Hematologist Oncology specialist and an Oncologist in Concord, New Hampshire. Dr. Weckstein is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Lung Cancer, Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Prostatectomy.
Foundation Medical Partners Inc
Gautami Rao is a Hematologist Oncology specialist and a Hematologist in Nashua, New Hampshire. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Paget Disease of the Breast, Intraductal Papilloma, Inflammatory Breast Cancer, and Hodgkin Lymphoma. Dr. Rao is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Crow isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Crow isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Lung CancerDr. Crow isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Crow isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Crow isDistinguished. Learn about Pleuropulmonary Blastoma.
- Richter SyndromeDr. Crow isDistinguished. Learn about Richter Syndrome.
- Advanced
- Acute Eosinophilic PneumoniaDr. Crow isAdvanced. Learn about Acute Eosinophilic Pneumonia.
- AgranulocytosisDr. Crow isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Crow isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Crow isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Crow isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Crow isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Crow isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Crow isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Crow isExperienced. Learn about Acute Myelomonocytic Leukemia.